openPR Logo
Press release

Burkitt Lymphoma Therapeutics Market Key Growth Drivers

01-10-2018 10:06 AM CET | Health & Medicine

Press release from: Persistence Market Research

Burkitt lymphoma is a form of non-Hodgkin's lymphomas (NHLs) which are a group of blood cancers derived from lymphocytes. Burkitt lymphoma is a rare disease and occurs only in one in every 30-50 people with non-Hodgkin's lymphomas. According to the World Health Organization (WHO), Burkitt lymphomas are of three types, namely, endemic, sporadic and immunodeficiency associated. Endemic NHL is also known as African type and affects African children aged between 4 to 7 years; this type of Burkitt lymphoma is closely associated with the Epstein-Barr virus (EBV), the main cause of glandular fever. Sporadic type occurs worldwide especially in western region. According to WebMD, in the United States and Western Europe, it accounts for up to 40% of all pediatric lymphoma cases. Immunodeficiency associated type of Burkitt lymphoma is more common in people with HIV/AIDS. Burkitt lymphoma is characterized by swelling of the lymph nodes in the neck, groin or under the arm which is often painless. This condition is more common in men than women.

Request Report For TOC @ https://www.persistencemarketresearch.com/toc/21130

It is one of the fastest growing lymphomas and becomes fatal if left untreated. Intensive chemotherapy has been proven to be successful in long term survival of more than half the people with this condition. Prednisone, cyclophosphamide, ifosfamide, vincristine, cytarabine, doxorubicin, methotrexate, and etoposide are the most commonly used medicines during chemotherapy. Geographically, North America leads the market for Burkitt lymphoma therapeutics owing to factors such as well-established reimbursement scenario in the region and significant number of Burkitt lymphoma cases diagnosed each year. According to WebMD, in the United States, around 1,200 new cases are diagnosed each year. Africa represents a potential market for Burkitt lymphoma therapeutics, however, poor economy of the region may hamper the market growth to some extent.

Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/21130

Takeda Pharmaceutical Company Limited, Novartis AG, Seattle Genetics, Inc., Sanofi, Mayo Clinic, MethylGene Inc., Eisai Inc. and Cellerant Therapeutics, Inc. are some major players and research laboratories among others engaged in the development, manufacturing and marketing of therapeutic agents used to treat Burkitt lymphoma.

Pre Book Full Report @ https://www.persistencemarketresearch.com/checkout/21130

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Persistence Market Research Pvt. Ltd

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

media@persistencemarketresearch.com

Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Burkitt Lymphoma Therapeutics Market Key Growth Drivers here

News-ID: 893241 • Views: 296

More Releases from Persistence Market Research

North America dry mix mortar market Development, Innovation, Opportunities And G …
The North America dry mix mortar market is anticipated to witness a growth rate of around 4.7% over the decade. Burgeoning construction sector, increasing urbanization, and rising individual living standards are expected to drive market expansion. Dry mix mortar is one of the key essential materials used in the construction & infrastructure industry. Growing construction industry, real-estate growth, and infrastructure developments are expected to boost demand for dry mix mortar over
North America Dry Mix Mortar Detailed Analysis In Forecast Year
The North America dry mix mortar market is anticipated to witness a growth rate of around 4.7% over the decade. Burgeoning construction sector, increasing urbanization, and rising individual living standards are expected to drive market expansion. Dry mix mortar is one of the key essential materials used in the construction & infrastructure industry. Growing construction industry, real-estate growth, and infrastructure developments are expected to boost demand for dry mix mortar over
Conductive Carbon Black Market Demand, Growth, Opportunities And Analysis Of Top …
Persistence Market Research has added a novel report on the global conductive carbon black market which is titled as 'Conductive Carbon Black Market: Global Industry Analysis and Forecast 2022-2031'. This report gives a detailed overview of the global conductive carbon black market and gives both value and volume forecast starting from year 2022 and ending in 2031. The report also gives extensive information on the market dynamics operating the global market
Bio Lubricants Market Demand, Growth Factors, Supply, Latest Rising Trend
Biolubricants Market: Introduction Lubricants are substances used for the lubrication of mechanical components. Conventional lubricants are generally produced using petroleum based feedstock. However, due to growing concern over the use of petroleum based lubricants which have hazardous impact on ecological system and in order to reduce dependency on petroleum feedstock, strong emphasis has been laid on development of sustainable alternatives to petroleum based lubricants. Biolubricants also known as bio-lubes are the

All 5 Releases


More Releases for Burkitt

Burkitt Lymphoma Treatment Market Poised to Expand at a Robust Pace Over 2027
Burkitt Lymphoma Treatment Market research report is the new statistical data source added by CMI. According to this report, Burkitt Lymphoma Treatment Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are
Burkitt Lymphoma Treatment Market Revenue Opportunies By Key Vendors Burkitt lym …
Burkitt lymphoma is a cancer of the lymphatic system, which develops from abnormal B lymphocytes and is characterized by rapid growth. Burkitt lymphoma usually causes lymph node enlargement in various parts of the body, including spleen, liver, bone marrow, and central nervous system. Burkitt lymphoma is a type of high-grade non-Hodgkin lymphoma (NHL). The World Health Organization has classified Burkitt lymphoma as an endemic that affects children in Africa aged
Global Burkitt Lymphoma Therapeutics Market 2018 Share, Size, Trends, Applicatio …
Burkitt Lymphoma is one of the rare types of B-cell non-Hodgkin’s lymphoma. It constitutes about 1-2% of all types of non-Hodgkins lymphoma types. It progresses at a very high rate and could be fatal if left untreated during the early stages. Global Burkitt Lymphoma Market to grow at a CAGR of 3.07% during the period 2018-2022. Get Sample@ https://www.researchbeam.com/global-burkitt-lymphoma-therapeutics-2018-2022-market/request-sample Covered in this report The report covers the present scenario and the growth
A Comprehensive Study exploring Burkitt Lymphoma Treatment Market | Key players …
A new business intelligence report released by HTF MI with title “2018-2025 Burkitt Lymphoma Treatment Report on Global and United States Market, Status and Forecast, by Players, Types and Applications” that targets and provides comprehensive market analysis with future prospects to 2025. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers
Burkitt Lymphoma Therapeutics - Pipeline Analysis 2018, Clinical Trials & Result …
Burkitt lymphoma is a rare, highly aggressive B-cell non-hodgkin lymphoma. Burkitt lymphoma disease may affect jaw, central nervous system, bowel, kidneys, ovaries, or other organs. Read market summary report : http://bit.ly/2FKQHOg There are three main types of Burkitt lymphoma: endemic, sporadic, and immunodeficiency-related. Endemic Burkitt lymphoma is the most common of the three types, originating in Africa, where it is still the most common childhood cancer. Endemic Burkitt lymphoma is rare
Global Burkitt Lymphoma Treatment Market Healthcare Status, Sales, Trends and In …
A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Burkitt Lymphoma Treatment Sales Market Research Report (2018-2025)” which provides an outlook of current market value as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% by the end of 2025. The report also studies the Burkitt Lymphoma Treatment Sales market worldwide, especially in North America, China,